{"organizations": [], "uuid": "05305df556955a0ad914a57dfabb99188f477c45", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-vertex-pharma-ceos-fy-2017-total-c/brief-vertex-pharma-ceos-fy-2017-total-compensation-17-3-mln-idUSFWN1RU16P", "country": "US", "domain_rank": 408, "title": "BRIEF-Vertex Pharma CEO's FY 2017 Total Compensation $17.3 Mln", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-17T23:09:00.000+03:00", "replies_count": 0, "uuid": "05305df556955a0ad914a57dfabb99188f477c45"}, "author": "", "url": "https://www.reuters.com/article/brief-vertex-pharma-ceos-fy-2017-total-c/brief-vertex-pharma-ceos-fy-2017-total-compensation-17-3-mln-idUSFWN1RU16P", "ord_in_thread": 0, "title": "BRIEF-Vertex Pharma CEO's FY 2017 Total Compensation $17.3 Mln", "locations": [], "entities": {"persons": [{"name": "jeffrey leiden", "sentiment": "none"}], "locations": [], "organizations": [{"name": "brief-vertex pharma ceo", "sentiment": "negative"}, {"name": "brief-vertex pharma", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "vertex pharmaceuticals inc", "sentiment": "none"}, {"name": "vertex pharmaceuticals inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 17, 2018 / 8:09 PM / Updated 11 minutes ago BRIEF-Vertex Pharma CEO's FY 2017 Total Compensation $17.3 Mln Reuters Staff 1 Min Read \nApril 17 (Reuters) - Vertex Pharmaceuticals Inc: \n* VERTEX PHARMACEUTICALS INC SAYS CEO JEFFREY LEIDEN'S FY 2017 TOTAL COMPENSATION WAS $17.3 MILLION VERSUS $17.4 MILLION IN FY 2016 - SEC FILING Source text ( bit.ly/2JVKbq6 ) Further company coverage:", "external_links": [], "published": "2018-04-17T23:09:00.000+03:00", "crawled": "2018-04-17T23:22:22.009+03:00", "highlightTitle": ""}